Melissa Terchek
Internal Medicine · Wilmington, NCNPI 1639280753
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 503 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,939 and has fallen 98.3% since, to $50 in 2025. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 503 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$726
- Amgen$666
- Pfizer$620
- UCB, Inc.$521
- Johnson & Johnson$473
- plus $3K from 26 others
What the payments were for
- Food & beverage$7,375100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,428 |
| GSK | 37 | $726 |
| Amgen(2 entities) | 50 | $666 |
| Pfizer | 61 | $620 |
| UCB, Inc. | 38 | $521 |
| Johnson & Johnson | 47 | $473 |
| Supernus Pharmaceuticals, Inc. | 44 | $420 |
| Novartis | 25 | $384 |
| Lilly USA, LLC | 23 | $375 |
| AstraZeneca(2 entities) | 12 | $309 |
| Collegium Pharmaceutical, Inc. | 12 | $226 |
| Radius Health, Inc. | 7 | $211 |
| E.r. Squibb & Sons, L.L.C. | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 3 | $118 |
| Mallinckrodt Hospital Products Inc. | 6 | $97 |
| Eisai Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $71 |
| Boehringer Ingelheim | 4 | $70 |
| Bristol Myers Squibb | 4 | $63 |
| Genentech USA, Inc. | 3 | $50 |
| Avanir Pharmaceuticals, Inc. | 2 | $44 |
| Sunovion Pharmaceuticals Inc. | 2 | $43 |
| Argenx US, Inc. | 1 | $35 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Nevro Corp. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,387 in reported general payments places this provider in the 90th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Wilmington
- Hector SanchezWilmington$193K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.